Skip to content

LSD: all studies

Page 57 of 282: studies 561 to 570 of 2,815, newest first. Back to the LSD overview

Research

Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro

Life Sciences June 1, 1998 Sabrina Giacomelli, Maura Palmery, Luca Romanelli et al. 51 citations

The hallucinogenic effects of lysergic acid diethylamide (LSD) have mainly been attributed to the interaction of this drug with the serotoninergic system, but it seems more likely that they are the result of the complex interactions of the drug with both the serotoninergic and dopaminergic systems. The aim of the present study was to investigate the functional actions of LSD at dopaminergic...

A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus

Progress in Neuro-Psychopharmacology and Biological Psychiatry May 1, 1998 Scott Helsley, David Fiorella, Richard A. Rabin et al. 30 citations

1. A series of N-substituted tryptamines was compared with a series of beta-carbolines in rats trained to discriminate LSD (0.1 mg/kg) from saline. 2. Intermediate levels of substitution were elicited by MDMT (76.4%), DMT (77.9%), and DET (48.7%). 6-F-DET produced 41.3% LSD-appropriate responding at a dose of 6.0 mg/kg but only 4 of 8 subjects completed the test session thus precluding...

DOI: 10.1016/s0278-5846(98)00031-1 (opens in new tab) Tryptamines Harmaline Hallucinogen Stimulus generalization +1

Optimization and immunological characterization of a photochemically coupled lysergic acid diethylamide (LSD) immunogen

Bioconjugate Chemistry 1998 Sarah Kerrigan, Donald. E. Brooks 3 citations

A photoreactive heterobifunctional linker was used to prepare an immunogen in which lysergic acid diethylamide was indirectly coupled to keyhole limpet hemocyanin at multiple sites on the drug. It was possible to attach approximately 35 drug molecules to each protein using approximately equal amounts of both species during the reaction. The presence of buffer components or water severely...

Epimerization Studies of LSD Using 1H Nuclear Magnetic Resonance (NMR) Spectroscopy

Journal of Analytical Toxicology October 1, 1997 S. J. Salamone, Z. Li, A. J. Mcnally et al. 23 citations

A study was conducted to determine the conditions needed to achieve the equilibrium concentration for the epimerization of d-lysergic acid diethylamide (LSD) to iso-LSD. The reaction was followed by integration of the C-9 resonance of LSD and iso-LSD by proton nuclear magnetic resonance (NMR). The C-9 resonance of LSD and iso-LSD appear as singlets at 6.35 and 6.27 ppm respectively. Starting...

DOI: 10.1093/jat/21.6.492 (opens in new tab) Lysergic acid diethylamide Epimer Proton nmr Analytical chemistry journal +3

Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users

Human Psychopharmacology: Clinical and Experimental September 1, 1997 A. C. Parrott, Marta Stuart 24 citations

Twenty-one recreational polydrug users (age range: 17–34 years), were recruited into the study using the 'snowball' technique (Solowij et al., 1992). All had used MDMA (3,4-methylenedioxymethamphetamine, or 'Ecstasy'), LSD (lysergic acid diethylamide), and amphetamine, on different occasions. They completed modified Profile of Mood States Questionnaires, to indicate their typical feeling states...

Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs.

Annals of clinical biochemistry September 1, 1997 D Simpson, R A Braithwaite, D R Jarvie et al. 38 citations

Requirements for the provision of an efficient and reliable service for drugs of abuse screening in urine have been summarized in Part I of this review. The requirements included rapid turn-around times, good communications between requesting clinicians and the laboratory, and participation in quality assessment schemes. In addition, the need for checking/confirmation of positive results...

DOI: 10.1177/000456329703400502 (opens in new tab) Full text (opens in new tab) Drug testing Forensic toxicology Quality assurance Legal compliance

Interference with testing for lysergic acid diethylamide

Clinical Chemistry April 1, 1997 Detlef Ritter, Cherise M Cortese, Linda C Edwards et al. 24 citations

Abstract We found a high rate (4.2%) of positive results for lysergic acid diethylamide (LSD) by Emit in 1898 urine samples that were submitted primarily from psychiatric patients for drugs-of-abuse (DOA) testing. Specimens that tested positive for LSD by Emit subsequently tested negative for LSD with two RIAs. Furthermore, LSD was not detected in randomly selected Emit-positive urine samples...

LSD before Leary: Sidney Cohen's Critique of 1950s Psychedelic Drug Research

Isis March 1, 1997 Steven J. Novak 68 citations

In 1962 Sidney Cohen presented the medical community with its first warning about the dangers of the drug LSD. LSD had arrived in the United States in 1949 and was originally perceived as a psychotomimetic capable of producing a model psychosis. But in the mid 1950s intellectuals in Southern California redefined LSD as a psychedelic capable of producing mystical enlightenment. Though LSD was an...

LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.

Journal of Pharmacology and Experimental Therapeutics September 1, 1996 Gerard J. Marek, George K. Aghajanian

Correlations between 5-hydroxytryptamine (5-HT) receptor binding affinities and human hallucinogenic potency have suggested that 5-HT2 receptors mediate the hallucinogenic effects of lysergic acid diethylamide (LSD) and phenethylamine hallucinogens. Electrophysiological studies have suggested that a subpopulation of gamma-aminobutyric acid (GABA)ergic interneurons in layer III of the rat...